After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ADAP belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Adaptimmune Therapeutics Plc ADR is $155.40M. A total of 0.93 million shares were traded on the day, compared to an average of 2.09M shares.
In the most recent transaction, Norry Elliot sold 5,584 shares of ADAP for 0.58 per share on Jan 17 ’25. After the transaction, the Chief Medical Officer now owns 7,510 company shares. In a previous transaction on Jan 17 ’25, Lunger John sold 5,584 shares at 0.58 per share. ADAP shares that Chief Patient Supply Officer owns now total 7,510.
Among the insiders who sold shares, Bertrand William C JR disposed of 5,584 shares on Jan 17 ’25 at a per-share price of $0.58. This resulted in the Chief Operating Officer holding 7,510 shares of ADAP after the transaction. In another insider transaction, Rawcliffe Adrian sold 30,601 shares at $0.58 per share on Jan 17 ’25. Company shares held by the Chief Executive Officer now total 44,327.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ADAP has a high of $2.05 and a low of $0.53.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ADAP’s latest balance sheet shows that the firm has $369.58M in Cash & Short Term Investments as of fiscal 2021. There were $25.47M in debt and $62.54M in liabilities at the time. Its Book Value Per Share was $0.31, while its Total Shareholder’s Equity was $205.96M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ADAP is Buy with a score of 4.00.
